• Alea Mills, Cold Spring Harbor Laboratories, New-York, USA, p53/p63/p73 mouse models
  • Alexander Zaika, University of Miami, USA, The formation of protein adducts causes inactivation of p53 protein and its aggregation
  • Antony Braithwaite, University of Otago, Dunedin, New-Zealand, Δ133p53 isoforms, ageing and inflammation (mouse models)
  • Bertrand Mollereau, ENS, University of Lyon, France, Combination of p53 isoforms define decision to induce autophagy (drosophila)
  • Bjorn Gjertsen, University of Bergen, Norway, p53 isoforms and Axl raeceptor
  • Cecilia Levandowski (Taatjes lab), University of Colorado Boulder, USA, Role of D40p53 in ageing process
  • Chandra Verma, A*Star, Singapore, p53 conformation
  • Christian Gaiddon, CNRS, IRFAC, Strasbourg, France, p63 and ALS/immune response
  • Claude Caron de Fromentel, CRCL, University of Lyon 1, France, p63/p73 isoforms
  • Curtis Harris, NCI, NIH, Bethesda, USA, p53 ageing/ipsc/ neuron/immunology
  • Daniele Bergamaschi, Queen Mary London University, London, UK, p63 and melanoma
  • David Lane, A*Star, Singapore, p53 isoforms in zebrafish
  • Elsa Flores, Moffitt Cancer Centre, Florida, USA, Unravelling the complexities of p63 and p73 to target mutant p53
  • Gerry Melino, University of Cambridge, UK and University of Rome Tor Vergata, Italy, Role of p53/p63/p73 isoforms in aging associated diseases
  • Gianni Del Sal, Università degli Studi di Trieste, Italy, p53 and ECM
  • James Manfredi, Icahn School of Medicine at Mount Sinai, New-York, USA, Mouse models with C-terminal mutation of p53
  • Jean-Christophe Bourdon, University of Dundee, UK, p53/p63/p73 isoforms
  • Jeff Pollard, University of Edinburgh, UK, Roles of macrophages in disease and repair and their phylogeny
  • Jo Zhou, Radboud University Medical Centre, Nijmegen, Netherlands, p63 affects epidermal cell identity through rewiring the enhancer landscape and chromatin architecture in skinkeratinocytes
  • Juan Tena, Universidad Pablo de Olavide, Seville, Spain, Roles of p63 during ectoderm specification (zebrafish)
  • Jun Chen, Zhejiang University, Hangzhou, China, p53 isoforms and heart regeneration (zebrafish)
  • Kelly Avery-Kiejda, University of Newcastle, HMRI, Australia, p53 isoforms in breast cancer
  • Klas Wiman, Karolinska Institute, Stockholm, Sweden, Small molecules reactivating p53
  • Laura Attardi, Stanford University School of Medicine, USA, p53/p63/p73 role in development in mouse models
  • Luisa Guerrini, Università degli Studi di Milano, Italy, p63 mediate cell response to thalidomide
  • Margareta Wilhelm, Karolinska Institute, Stockholm, Sweden, p53 and p73 isoforms in human neural stem cells
  • Maria C. Marin, University of Leon, Spain, p73 an architect of epithelial tissue (cell (re)programming, p73 ciliogenesis),
  • Massimo Levrero, CRCL, University of Lyon 1, France, p73 and virus
  • Max Wellenstein (K. De Visser lab), Netherlands Cancer Institute, Amsterdam, Netherlands, Cancer cell-intrinsic p53 status dictates systemic pro-metastatic inflammation
  • Michael Kastan, Duke Cancer Institute, Durham, USA, p53 splicing and irradiation
  • Neda Slade, Ruđer Bošković Institute, Zagreb, Croatia, p53/p73 in melanoma
  • Olivier Terrier, CNRS, CIRI, University Claude Bernard, Lyon, France, The cross-talk between flu virus protein and p53 isoforms
  • Pierre Roux, CNRS, CRBM, Montpellier, France, Δ133p53β and EMT
  • Simon Mc Dade, Queen's University Belfast, UK, Functional genomics identifies a novel p53 induced ligand-independent TRAIL-R2/FLIP complex as a novel therapeutic vulnerability
  • Sue Haupt, University of Melbourne, Australia, p53 and MDMx isoforms
  • Thomas Meyer, Max Planck Institute for Infection Biology, Berlin, Germany, p53 and H. Pylori
  • Tom Van Wezel, Leiden University Medical Center, Leiden, Netherlands, Mutant p53 isoforms
  • Varda Rotter, Weizmann Institute of Science, Rehovot, Israel, p53 small reactivating molecules
  • Volker Doetsch, Goethe University, Frankfurt, Germany, Structure p63 protein
  • Xinbin Chen, University of California at Davis, USA, p63/p73/immune defect/regeneration
  • Yari Ciribilli, University of Trento, Italy, The impact of p53 isoforms expression in lung cancer
  • Ygal Haupt, University of Melbourne, Australia, p53 and MDM2 isoforms

This site uses cookies.

Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.